how much ghk cu should you inject ghk-cu recommended dosage subcutaneous injection ghk-cu peptide injection sites GHK-Cu Dosage and Protocol: A Medical Provider's Guide to the GHK-Cu I – ghk cu injection dose dosage

Cell 93 (2), 189201

Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume

Quality and sourcing considerations DSIP is not FDA-approved and exists in a regulatory gray area as a research chemical

For several years, this market boomed in a legal gray area

Epithalon is not approved for human use in non-research settings